Clinical Trial

Bioequivalence Study of GZR4 Injection With Different Manufacturing Processes in Healthy Adult Participants

Not Yet Recruiting Phase 1
View on ClinicalTrials.gov →
Record status
This record was last updated June 26, 2026 (before its estimated July 29, 2026 completion). Its status may not reflect the trial's current state.
Summary
This study is a single-center, open-label, randomized, single-dose bioequivalence trial conducted in healthy adult participants.
Trial Details
NCT Number NCT07670897
Lead Sponsor Gan & Lee Pharmaceuticals.
Conditions T2D
Enrollment 64 participants
Start Date 2026-07-01
Primary Completion 2026-07-29 (estimated)
Study Completion 2026-07-29 (estimated)
Updated on ClinicalTrials.gov 2026-06-26